Expert Highlights Common Signs of Chemo Brain

News
Video

Patients experiencing chemotherapy-related cognitive impairment may forget where they put things or even stop paying their bills, an expert said.

Chemotherapy treatment can affect a person’s memory, leading to a condition commonly referred to as chemotherapy-induced cognitive impairment, or, more commonly, “chemo brain.”

According to Jennifer Cargile, a speech-language pathologist at City of Hope in Atlanta, explained some of the common signs of short-term memory deficits caused by chemotherapy treatment, such as losing or forgetting belongings and forgetting to pay bills.

READ MORE:Acknowledging Cancer-Related Cognitive Impairment May Be Best Treatment for Breast Cancer Survivors Versus Physical, Mindfulness Exercises

Transcript

I find a lot of short-term memory deficits in terms of forgetting where they put their belongings. I have a lot of patients report that it takes them five or six times to actually get out of their house.

They go to their car, and they're like, “Oh, where's my keys?” So they get back in, they grab the keys, they come back out, they go, “Oh, no, I didn't get my wallet.” They go back in, they come back out like, “I did, I lock the door?” They go back in. And so they say it takes them five or six times to actually get out the door each day.

They (also) misplace belongings. So it could be that or (thinking), they can't remember where they put their glasses or cell phone goes missing. I had a patient yesterday tell me she's lost her debit card three times in the last two months, (and she) had to order a new debit card. So those are examples of short-term memory deficit that you may see.

The other issue also with short-term memory is forgetting to pay bills. This is a big one. And I have a lot of patients show up in my office because they paid bills all their lives, and suddenly they're missing bills. So when I say “Have you had trouble paying your bills?” (They respond) “Oh my gosh, yeah. How did you know that?” So that's just another example the short-term memory deficit they may be experiencing.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Related Content